| LEXXW Stock | | | USD 0.80 0.05 6.67% |
Lexaria Bioscience financial indicator trend analysis is infinitely more than just investigating Lexaria Bioscience Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexaria Bioscience Corp is a good investment. Please check the relationship between Lexaria Bioscience Other Operating Expenses and its Cost Of Revenue accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
Other Operating Expenses vs Cost Of Revenue
Other Operating Expenses vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexaria Bioscience Corp Other Operating Expenses account and
Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Lexaria Bioscience's Other Operating Expenses and Cost Of Revenue is -0.48. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Lexaria Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Lexaria Bioscience's Other Operating Expenses and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Lexaria Bioscience Corp are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Other Operating Expenses i.e., Lexaria Bioscience's Other Operating Expenses and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | -0.48 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Lexaria Bioscience Corp. It is also known as Lexaria Bioscience overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Cost Of Revenue
Cost of Revenue is found on Lexaria Bioscience Corp income statement and represents the costs associated with goods and services Lexaria Bioscience provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Lexaria Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexaria Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
At this time, Lexaria Bioscience's
Issuance Of Capital Stock is fairly stable compared to the past year.
Enterprise Value Over EBITDA is likely to climb to 395.77 in 2024, whereas
Selling General Administrative is likely to drop slightly above 2.5
M in 2024.
| 2021 | 2023 | 2024 (projected) |
Other Operating Expenses | 7.6M | 6.2M | 3.2M | Interest Expense | 114.3K | 102.9K | 125.2K |
Lexaria Bioscience fundamental ratios Correlations
Click cells to compare fundamentals
Lexaria Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexaria Bioscience fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to
measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to
predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.